Manifestations of Von Hippel Lindau syndrome: a retrospective national review

被引:9
|
作者
O'Brien, F. J. [1 ]
Danapal, M. [1 ]
Jairam, S. [1 ]
Lalani, A. K. [1 ]
Cunningham, J. [2 ]
Morrin, M. [2 ]
Mcnally, S. [3 ]
Donovan, M. G. [4 ]
Little, D. [4 ]
Tuthill, A. [5 ]
Conlon, P. J. [1 ]
机构
[1] Beaumont Hosp, Dept Nephrol, Dublin 9, Ireland
[2] Beaumont Hosp, Dept Radiol, Dublin 9, Ireland
[3] Beaumont Hosp, Dept Neurosurg, Dublin 9, Ireland
[4] Beaumont Hosp, Dept Urol Transplantat, Dublin 9, Ireland
[5] Cork Univ Hosp, Dept Med & Endocrinol, Cork, Ireland
关键词
ENDOLYMPHATIC SAC TUMORS; CENTRAL-NERVOUS-SYSTEM; NATURAL-HISTORY; GERMLINE MUTATIONS; DISEASE; HEMANGIOBLASTOMAS; PHEOCHROMOCYTOMAS; MANAGEMENT; FAMILIES;
D O I
10.1093/qjmed/hct249
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Von Hippel Lindau (VHL) disease is a syndrome that is defined by variety of tumours such as cerebellar haemangioblastomas, renal cell carcinomas, phaeochromocytomas, pancreatic adenomas and ear, nose and throat (ENT) adenomas. This disease is often genetic and inherited in an autosomal dominant fashion, and can present in childhood, adolescence or adult life. This study describes the presentation, natural history and manifestations of patients attending our institutions with this condition. We aim to highlight the importance of screening in diagnosing the manifestations of VHL. Methods: A retrospective review was performed on all patients diagnosed with VHL and coded as such by the national Hospital Inpatient Enquiry Scheme at Beaumont Hospital Dublin and Cork University Hospital. This was performed over a 20 years period between 1989 and 2009. Age, sex, mode of presentation, presence or absence of end stage kidney disease and genotype were documented. Presence or absence of the characteristic tumours of VHL was also recorded, as were the initial presenting features of these tumours. Results: Thirty-six patients were diagnosed with VHL. These patients ranged from 18 to 78 years old. Three patients were members of the Irish travelling community. The most frequent mode of presentation was altered neurological signs (40%), with a significant proportion presenting with haematuria (23%). Patients diagnosed prior to 1995 were more likely to have presented with significant complications of VHL, while those diagnosed after this time were more likely to have been diagnosed via screening. Genetic testing was performed on 17 patients; those who did not have genetic testing performed were more likely to have been diagnosed prior to the era of genetic testing. Thirty-one patients had received screening for complications of VHL including renal cell carcinomas, central nervous system (CNS) haemangioblastomas and phaeochromocytomas. The patients who did not receive any screening presented with neurological symptoms. Conclusion: Beaumont Hospital Dublin and Cork University Hospital are tertiary referral centres for nephrology, urology and neurosurgery and deals with a significant proportion of patients diagnosed with VHL in Ireland. This study highlights the significant burden of this illness and emphasizes the importance of screening for these renal/CNS and ENT complications. This study also highlights the importance of family screening in diagnosing this condition.
引用
收藏
页码:291 / 296
页数:6
相关论文
共 50 条
  • [41] von Hippel-Lindau disease: Diagnosis and factors influencing disease outcome
    Binderup, Marie Louise Molgaard
    DANISH MEDICAL JOURNAL, 2018, 65 (03):
  • [42] Von Hippel-Lindau: How a rare disease illuminates cancer biology
    Richard, Stephane
    Gardie, Betty
    Couve, Sophie
    Gad, Sophie
    SEMINARS IN CANCER BIOLOGY, 2013, 23 (01) : 26 - 37
  • [43] Von Hippel-Lindau Syndrome: Implications for Nursing Care
    Mahon, Suzanne M.
    Waldman, Laura
    ONCOLOGY NURSING FORUM, 2012, 39 (06) : 533 - 535
  • [44] How 'eye' helped in von Hippel-Lindau syndrome
    Tyagi, Swati
    Kumar, Kritika Chopra
    Saluja, Komal
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2023, 33 (01) : NP5 - NP9
  • [45] Von Hippel-Lindau syndrome with pancreatic adenocarcinoma (with videos)
    Zhang, Chenchen
    Zhong, Ning
    Wang, Xiao
    Qi, Qingqing
    Li, Zhen
    ENDOSCOPIC ULTRASOUND, 2021, 10 (04) : 311 - 312
  • [46] Compliance with periodic surveillance for Von-Hippel-Lindau disease
    Lammens, Chantal R. M.
    Aaronson, Neil K.
    Hes, Frederik J.
    Links, Thera P.
    Zonnenberg, Bernard A.
    Lenders, Jacques W. M.
    Majoor-Krakauer, Danielle
    Van Os, Theo A. M.
    Gomez-Garcia, Encarna B.
    de Herder, Wouter
    van der Luijt, Rob B.
    van den Ouweland, Ans M. W.
    Van Hest, Liselot P.
    Verhoef, Senno
    Bleiker, Eveline M. A.
    GENETICS IN MEDICINE, 2011, 13 (06) : 519 - 527
  • [47] Assessment of Tumor Growth in Pancreatic Neuroendocrine Tumors in von Hippel Lindau Syndrome
    Weisbrod, Allison B.
    Kitano, Mio
    Thomas, Francine
    Williams, David
    Gulati, Neelam
    Gesuwan, Krisana
    Liu, Yixun
    Venzon, David
    Turkbey, Ismail
    Choyke, Peter
    Yao, Jack
    Libutti, Steven K.
    Nilubol, Naris
    Linehan, William M.
    Kebebew, Electron
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 218 (02) : 163 - 169
  • [48] Evidence for genetic anticipation in von Hippel-Lindau syndrome
    Aronoff, Laura
    Malkin, David
    van Engelen, Kalene
    Gallinger, Bailey
    Wasserman, Jonathan
    Kim, Raymond H.
    Villani, Anita
    Meyn, M. Stephen
    Druker, Harriet
    JOURNAL OF MEDICAL GENETICS, 2018, 55 (06) : 395 - 402
  • [49] Von Hippel-Lindau is Associated to Pancreatic Neuroendocrine Tumors: A Comprehensive Review
    Coco, Danilo
    Leanza, Silvana
    JOURNAL OF KIDNEY CANCER AND VHL, 2023, 10 (02): : 13 - 20
  • [50] Ovarian Steroid Cell Tumor in an Adolescent With Von Hippel-Lindau Syndrome: A Case Report and Review of the Literature
    Marques, Ana
    Portugal, Raquel
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2020, 39 (05) : 473 - 477